<DOC>
	<DOCNO>NCT02635828</DOCNO>
	<brief_summary>Postoperative nausea vomiting ( PONV ) displease experience distress surgical patient first 24 hour surgical procedure . The incidence postoperative nausea occur 50 % , incidence postoperative vomit 30 % , high-risk patient , PONV rate could high 80 % . Therefore , study design single arm , non-randomized , pilot study assess efficacy safety profile triple therapy combination palonosetron , dexamethasone promethazine prevent PONV patient undergo craniotomy general anesthesia .</brief_summary>
	<brief_title>Effectiveness Triple Therapy With Palonosetron PON Prophylaxis</brief_title>
	<detailed_description>At induction anesthesia , triple therapy palonosetron 0.075 mg IV , dexamethasone 10 mg IV promethazine 25 mg IV give PONV prophylaxis . After surgery , subject transfer surgical intensive care unit ( SICU ) post anesthesia care unit clinically indicate . Ondansetron 4 mg IV administer primary rescue medication subject PONV symptom . PONV assess collect every 24 hour 5 day via direct interview and/or medical chart review .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Adult patient , 18 85 year age , race gender . With American Society Anesthesiologist ( ASA ) physical status I III schedule undergo neurological surgery require open cranium Dura matter general anesthesia , Ohio State University Medical Center consent write participate study . Post operative hospitalization expect last least 72 hour . Subjects whose surgery expect require least 1 hour general anesthesia Subjects negative serum urine pregnancy test within 1 day surgery surgically sterilize postmenopausal . Subjects prisoner , pregnant , mentally ill , age 18 age 85 , ASA classification V , alcohol drug abuser . Subjects know hypersensitivity 5HT3 antagonist , agent part anesthesia regimen , medication administer protocol . Subjects breastfeed . Subjects retching/vomiting moderate severe nausea 24 hour prior anesthesia suffer chronic nausea and/or vomit Subjects treated drug treatment antiemetic efficacy within last 24 hour prior start treatment . Subjects participate clinical trial investigational drug within 30 day prior surgery . Subjects participate clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Palonosetron</keyword>
	<keyword>Craniotomy</keyword>
	<keyword>Nausea</keyword>
	<keyword>Vomiting</keyword>
</DOC>